Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Part of paid clinical trials in Duarte, California.
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study ID
- NCT01027000
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 69 Years
- Healthy Volunteers
- Not accepted
Interventions
- rituximab — BIOLOGICAL
- busulfan — DRUG
- cyclophosphamide — DRUG
- fludarabine phosphate — DRUG
- methotrexate — DRUG
- sirolimus — DRUG
- tacrolimus — DRUG
- allogeneic stem cell transplant — PROCEDURE
Study Details
RATIONALE: Giving low doses of chemotherapy before a donor stem cell transplant helps stop the growth of cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells. Also, monoclonal antibodies, such as rituximab, can find cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving tacrolimus, sirolimus, and methotrexate after the transplant may stop this from happening. PURPOSE: This phase II trial is studying how well donor stem cell transplant works in treating patients with high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma.
Key Dates
- Start date
- Feb 28, 2010
- Status verified
- Apr 2023
- Primary completion
- Jan 31, 2016
- Completion
- Apr 30, 2023
Study Design
- Enrollment
- 68 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (Combination of chemotherapy and transplant)See detailed description
Primary Outcome Measure
2-year Progression-free Survival in Early Disease Participants [ Time Frame: 2 years post-registration ]
Locations (25)
Find similar trials in Duarte, CA
Related Studies
- Bone Marrow Grafting for Leukemia and LymphomaEnrolling By Invitation · Stanford University · Stanford, California
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- Registry of Older Patients With CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Boone, North Carolina